Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Swiss Life Holding AG ADR

Start price
Target price
Perf. (%)
€15.38
07.08.20
€18.00
04.11.21
10.74%
11.11.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
buy
STS Group AG

Start price
Target price
Perf. (%)
€3.07
21.10.20
€3.00
04.11.21
3.26%
10.11.20

Future proof or reliable business model
Could be very worthwhile Investment >20% year
Leading role in innovation
Revenue growth >5% per year expected
Jumia Technologies AG

Start price
Target price
Perf. (%)
€9.86
19.08.20
€6.00
04.11.21
54.16%
04.11.20

Good rating
Standard Investments for future growth
High valuation
Very low/no dividend yield expected
buy
Nikola Corp.

Start price
Target price
Perf. (%)
€15.65
30.10.20
€17.00
02.11.20
4.15%
02.11.20

Risky Investment
Phunware Inc.

Start price
Target price
Perf. (%)
€0.70
23.09.20
-
22.10.20
-11.43%
22.10.20

Risky Investment
buy
Essity Ab

Start price
Target price
Perf. (%)
€26.36
25.03.20
€30.00
20.10.20
10.02%
20.10.20

buy
Xtant Medical Holdings Inc.

Start price
Target price
Perf. (%)
€1.10
05.10.20
€0.000
19.10.20
18.18%
19.10.20

Fair valuation
Risky Investment
Risky balance sheet
Below average Management
Interpace Biosciences Inc.

Start price
Target price
Perf. (%)
€3.62
14.10.20
€2.00
17.10.20
-9.39%
17.10.20

Risky Investment
Nikola Corp.

Start price
Target price
Perf. (%)
€20.90
02.10.20
-
13.10.20
0.48%
13.10.20

Risky Investment
buy
Satsuma Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€3.66
21.09.20
-
02.10.20
-8.20%
02.10.20

Good culture
Could be very worthwhile Investment >20% year
Capable Management
Few uniques
buy
Bonesupport Holding Ab

Start price
Target price
Perf. (%)
€4.81
07.09.20
€10.00
29.09.20
16.84%
29.09.20

Could be very worthwhile Investment >20% year
Market Leader or Top 3
Very Future proof/growth oriented business model
Nikola Corp.

Start price
Target price
Perf. (%)
€23.10
23.09.20
-
24.09.20
-39.39%
24.09.20

Risky Investment
overvalued
Phunware Inc.

Start price
Target price
Perf. (%)
€0.78
05.09.20
-
23.09.20
-10.26%
23.09.20

Risky Investment
Desert Mountain Energy Corp.

Start price
Target price
Perf. (%)
€0.18
21.09.20
-
21.09.20
-
21.09.20

Could be very worthwhile Investment >20% year
Desert Mountain Energy Corp.

Start price
Target price
Perf. (%)
€1.10
21.09.20
-
21.09.20
-4.55%
21.09.20

Could be very worthwhile Investment >20% year
Desert Mountain Energy Corp.

Start price
Target price
Perf. (%)
€1.00
08.09.20
-
21.09.20
10.00%
21.09.20

Could be very worthwhile Investment >20% year
buy
Satsuma Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.60
10.09.20
-
19.09.20
-32.50%
19.09.20

Good culture
Could be very worthwhile Investment >20% year
Capable Management
Few uniques
Wirecard AG ADR

Start price
Target price
Perf. (%)
€0.56
23.08.20
-
05.09.20
-9.82%
05.09.20

Probably not worthwhile Investment
buy
Inspire Medical Systems Inc.

Start price
Target price
Perf. (%)
€95.00
22.08.20
-
04.09.20
4.21%
04.09.20

Groupon Inc.

Start price
Target price
Perf. (%)
€22.30
08.08.20
-
03.09.20
29.60%
03.09.20

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
Wirecard AG ADR

Start price
Target price
Perf. (%)
€0.56
24.08.20
-
02.09.20
18.75%
02.09.20

Risky Investment
Deficits in Management
Very bad culture
Mainly gamblers invest here
NAGA Group

Start price
Target price
Perf. (%)
€2.16
03.05.20
€1.64
17.08.20
-3.70%
17.08.20

buy
Givaudan Sa

Start price
Target price
Perf. (%)
€59.06
24.01.20
€75.00
13.08.20
21.55%
13.08.20

buy
Fastly Inc.

Start price
Target price
Perf. (%)
€93.00
05.08.20
€100.00
06.08.20
-19.89%
06.08.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
buy
Fsd Pharma Inc.

Start price
Target price
Perf. (%)
€6.20
03.06.20
€10.00
01.07.20
-42.53%
01.07.20